Perspectives for pharmaceutical screening at XFEL sources using the example of Lassa virus endonuclease

Falke, S.; Reinke, P.Y.A.; Rosenberg, D.; Fischer, P.; Meyer, J.; Galchenkova, M.; Tolstikova, A.; Mariani, V.; Senst, J.M.; Lewe, P.; Witt, S.; Wagner, A.; Chapman, H.N.; Hunter, M.; Günther, S.; Meents, A.

doi:10.1107/S2059798326009435

Figure 3
I/σ(I) and CC_1/2 depending on the resolution shells of the diffraction data sets collected using SFX, SSX and single-crystal rotational crystallography: (a, d) LASVendoN apo data sets, (b, e) in complex with DPBA and (c, f) in complex with BXA. The maximum resolution was determined based on I/σ(I). The completeness in the outer resolution shell of all datasets is 100%. Further parameters are listed in Table 1

STRUCTURAL
BIOLOGY

ISSN: 2059-7983

Volume 82| Part 10| October 2026| Pages 1181-1194

https://doi.org/10.1107/S2059798326009435

Open

access